287 related articles for article (PubMed ID: 30387390)
21. Understanding the prospective of nano-formulations towards the treatment of psoriasis.
Pradhan M; Alexander A; Singh MR; Singh D; Saraf S; Saraf S; Ajazuddin
Biomed Pharmacother; 2018 Nov; 107():447-463. PubMed ID: 30103117
[TBL] [Abstract][Full Text] [Related]
22. Topical Drug Delivery of Anti-infectives Employing Lipid-Based Nanocarriers: Dermatokinetics as an Important Tool.
Thakur K; Sharma G; Singh B; Katare OP
Curr Pharm Des; 2018; 24(43):5108-5128. PubMed ID: 30657036
[TBL] [Abstract][Full Text] [Related]
23. Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis.
Agrawal U; Gupta M; Vyas SP
Artif Cells Nanomed Biotechnol; 2015 Feb; 43(1):33-9. PubMed ID: 24040836
[TBL] [Abstract][Full Text] [Related]
24. Liposome Based Drug Delivery for the Management of Psoriasis - A Comprehensive Review.
Bahadur S; Sharma M
Curr Pharm Biotechnol; 2023; 24(11):1383-1396. PubMed ID: 36518042
[TBL] [Abstract][Full Text] [Related]
25. Development and Characterization of a Clobetasol Propionate Nanostructured Lipid Carrier-Based Gel for the Treatment of Plaque Psoriasis.
Dadwal A; Mishra N; Narang RK
Curr Mol Pharmacol; 2021; 14(3):399-411. PubMed ID: 32598275
[TBL] [Abstract][Full Text] [Related]
26. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis.
Katari O; Jain S
Expert Opin Drug Deliv; 2021 Dec; 18(12):1857-1872. PubMed ID: 34823429
[TBL] [Abstract][Full Text] [Related]
27. Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.
Fereig SA; El-Zaafarany GM; Arafa MG; Abdel-Mottaleb MMA
Drug Deliv; 2020 Dec; 27(1):662-680. PubMed ID: 32393082
[TBL] [Abstract][Full Text] [Related]
28. An Innovative Approach in Nanotechnology-based Delivery System for the Effective Management of Psoriasis.
Parveen S; Ahmed M; Baboota S; Ali J
Curr Pharm Des; 2022; 28(13):1082-1102. PubMed ID: 35105284
[TBL] [Abstract][Full Text] [Related]
29. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
Jain S; Addan R; Kushwah V; Harde H; Mahajan RR
Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706
[TBL] [Abstract][Full Text] [Related]
30. Promising Strategies of Colloidal Drug Delivery-Based Approaches in Psoriasis Management.
Singh S; Sharma N; Behl T; Sarkar BC; Saha HR; Garg K; Singh SK; Arora S; Amran MS; Abdellatif AAH; Bilgrami AL; Ashraf GM; Rahman MS
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834393
[TBL] [Abstract][Full Text] [Related]
31. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
32. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
Eur J Pharm Sci; 2017 Jun; 104():315-325. PubMed ID: 28408348
[TBL] [Abstract][Full Text] [Related]
33. Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics.
Amarji B; Garg NK; Singh B; Katare OP
J Drug Target; 2016; 24(2):147-60. PubMed ID: 26204326
[TBL] [Abstract][Full Text] [Related]
34. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
[TBL] [Abstract][Full Text] [Related]
35. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis.
Gomes GS; Frank LA; Contri RV; Longhi MS; Pohlmann AR; Guterres SS
Int J Pharm; 2023 Jan; 631():122535. PubMed ID: 36566826
[TBL] [Abstract][Full Text] [Related]
36. Natural medicine combined with nanobased topical delivery systems: a new strategy to treat psoriasis.
Zhao Z; Liu T; Zhu S; Pi J; Guo P; Qi D; Liu Z; Li N
Drug Deliv Transl Res; 2022 Jun; 12(6):1326-1338. PubMed ID: 34287767
[TBL] [Abstract][Full Text] [Related]
37. Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier.
Ramanunny AK; Wadhwa S; Thakur D; Singh SK; Kumar R
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):418-433. PubMed ID: 32496998
[TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619
[TBL] [Abstract][Full Text] [Related]
39. Lipid-Based Nanoparticles as Carriers for Dermal Delivery of Antioxidants.
Lucia M
Curr Drug Metab; 2017; 18(5):469-480. PubMed ID: 28228079
[TBL] [Abstract][Full Text] [Related]
40. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
